Pi-Cardia announced today that CMS approved reimbursement for its ShortCut leaflet modification device for TAVR procedures.

An Abbott official said today that the company launched its latest-generation MitraClip and TriClip G5 systems.

Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, announced today the first commercial procedur ...

Assessment of left ventricular systolic function is essential for diagnosing and managing cardiac diseases and provides ...